Get started
Author

Yule Chen

Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial–mesenchymal transition and stemness
2013 · Kaijie Wu, Zhongyun Ning, et al. · Cellular Signalling · 115
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
2018 · Jingyi Liu, Zhibing Duan, et al. · Nature Communications · 104
PDF
De Novo Design of an Androgen Receptor DNA Binding Domain‐Targeted peptide PROTAC for Prostate Cancer Therapy
2022 · Bohan Ma, Yizeng Fan, et al. · Advanced Science · 85
PDF
PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription
2012 · Kaijie Wu, Jinhai Fan, et al. · Cellular Signalling · 84
Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria
2011 · Jin Zeng, Yi Sun, et al. · Molecular Cancer Therapeutics · 72
Kaempferol induces cell cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38 signaling
2014 · WENBIN SONG, QIANG DANG, et al. · Oncology Reports · 63
PDF
Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: Involvement of cell cycle arrest and apoptosis induction
2012 · XIN-LAN LU, JIN ZENG, et al. · International Journal of Oncology · 60
PDF
Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription
2015 · Yang Gao, Kaijie Wu, et al. · Oncotarget · 56
PDF
Autophagy Induction by Silibinin Positively Contributes to Its Anti-Metastatic Capacity via AMPK/mTOR Pathway in Renal Cell Carcinoma
2015 · Feng Li, Zhenkun Ma, et al. · International Journal of Molecular Sciences · 56
PDF
G Protein γ subunit 7 loss contributes to progression of clear cell renal cell carcinoma
2019 · Shan Xu, Haibao Zhang, et al. · Journal of Cellular Physiology · 49
PDF
Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development
2012 · Kaijie Wu, Jin Zeng, et al. · Urologic Oncology Seminars and Original Investigations · 47
A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
2024 · Bohan Ma, Donghua Liu, et al. · Journal of Medicinal Chemistry · 44
MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation
2024 · Jian Ma, Lei Li, et al. · Nature Communications · 44
PDF
Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer
2021 · Yizeng Fan, Tao Hou, et al. · Autophagy · 44
PDF
Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma
2014 · Jiancheng Zhou, Zhuo Deng, et al. · Urologic Oncology Seminars and Original Investigations · 41
DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS
2020 · Min Jiao, Hui Guo, et al. · Biomedicine & Pharmacotherapy · 40
PDF
Activation of PSGR with β-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocation
2019 · Hongjun Xie, Tianjie Liu, et al. · Cancer Letters · 40
Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation
2019 · Zhao Yang, Jiaqi Chen, et al. · Cancer Letters · 39
Development of a Double-Stapled Peptide Stabilizing Both α-Helix and β-Sheet Structures for Degrading Transcription Factor AR-V7
2024 · Bohan Ma, Donghua Liu, et al. · JACS Au · 37
Twist Confers Chemoresistance to Anthracyclines in Bladder Cancer through Upregulating P-Glycoprotein
2012 · Yule Chen, Lei Li, et al. · Chemotherapy · 37
Reciprocal Regulation of Hypoxia-Inducible Factor 2α and GLI1 Expression Associated With the Radioresistance of Renal Cell Carcinoma
2014 · Jiancheng Zhou, Kaijie Wu, et al. · International Journal of Radiation Oncology*Biology*Physics · 36
Discovery of a peptide proteolysis-targeting chimera (PROTAC) drug of p300 for prostate cancer therapy
2024 · Dize Zhang, Bohan Ma, et al. · EBioMedicine · 34
PDF
Decreased glucose bioavailability and elevated aspartate metabolism in prostate cancer cells undergoing epithelial‐mesenchymal transition
2020 · Yule Chen, Ke Wang, et al. · Journal of Cellular Physiology · 32
DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling
2015 · Kaijie Wu, Bin Wang, et al. · Cellular Signalling · 31
Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma
2018 · Wenbin Song, Dalin He, et al. · Molecular Oncology · 30
PDF
Works count: 78
Citation count: 1,678
H-index: 27
I10-index: 43
Year
Topic
Type